Conjugated linoleic acid (CLA): Is it time to supplement asthma therapy? - 04/09/11
, Delbert R. Dorscheid 
Corresponding author. Providence Healthcare Heart + Lung Institute, Room 166, St. Paul’s Hospital, Vancouver, Canada V6Z1Y6. Tel.: +1 6046822344; fax: +1 6048068351.Abstract |
The limitations and side effects of existing asthma therapies prompt interest in complementary and alternative therapies. Conjugated linoleic acids (CLA) are a family of natural fatty acids found primarily in beef and dairy products. These molecules have a variety of biological properties which suggest potential benefit in asthma, including effects on energy regulation, lipid metabolism, inflammation and immune function. Here we review the evidence for these effects from pre-clinical and clinical studies, their significance in the context of human asthma, and discuss the potential role for CLA supplementation in asthma management.
Le texte complet de cet article est disponible en PDF.Keywords : Conjugated linoleic acid, Complementary and alternative medicine, Adipokine, PPARgamma, Asthma
Plan
Vol 24 - N° 5
P. 540-548 - octobre 2011 Retour au numéro
Article précédent
- Multiscale mathematical models of airway constriction and disease
- Graham M. Donovan
- Reevaluation of the efficacy and safety of the neutrophil elastase inhibitor, Sivelestat, for the treatment of acute lung injury associated with systemic inflammatory response syndrome; a phase IV study
- Naoki Aikawa, Akitoshi Ishizaka, Hiroyuki Hirasawa, Shuji Shimazaki, Yasuhiro Yamamoto, Hisashi Sugimoto, Masahiro Shinozaki, Nobuyuki Taenaka, Shigeatsu Endo, Toshiaki Ikeda, Yasushi Kawasaki
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?